NASDAQ: RNTXRein Therapeutics Inc Stock Ownership - Who owns Rein Therapeutics?
Insider buying vs selling
Have Rein Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Brian Windsor | President and CEO | 2024-12-05 | 239 | $2.24 | $535.36Buy |
| James Brian Windsor | President and CEO | 2024-12-05 | 161 | $2.25 | $362.25Buy |
RNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RNTX insiders and whales buy or sell their stock.
RNTX Shareholders
What type of owners hold Rein Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Muneer A. Satter | 71.27% | 16,609,449 | $21.09M | Insider |
| Reinhard J. Ambros | 10.94% | 2,549,982 | $3.24M | Insider |
| Novartis Bioventures Ltd | 8.92% | 2,079,394 | $2.64M | Insider |
| Of Texastexas Am Investment Managment Co University | 7.77% | 1,810,457 | $2.30M | Insider |
| University Of Texastexas Am Investment Management Co | 7.49% | 1,746,549 | $2.22M | Insider |
| Bios Capital Management LP | 7.25% | 1,690,751 | $2.15M | Institution |
| Voss Capital LP | 6.15% | 1,433,686 | $1.82M | Institution |
| Brian M. Gallagher Jr. | 6.14% | 1,431,519 | $1.82M | Insider |
| Armen Shanafelt | 4.70% | 1,094,987 | $1.39M | Insider |
| LV Management Group LLC | 4.70% | 1,094,987 | $1.39M | Insider |
RNTX vs Biotech Stocks
Rein Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.